Results 191 to 200 of about 448,654 (259)

Targeting the PGRN‐BMP Lysosomal Axis With NPs@PGRN Reverses Immunometabolic Dysfunction in Chronic Septic Arthritis

Advanced Science, EarlyView.
Chronic septic arthritis involves intracellular bacterial persistence and lipid‐immune crosstalk via the PGRN‐BMP lysosomal axis. A dual‐targeting nanoparticle system (NPs@PGRN) restores lysosomal bactericidal function, reduces bacterial burden, and reprograms macrophage immunity, offering a novel therapeutic strategy. ABSTRACT Chronic septic arthritis,
Congsun Li, Jiaqi Fan, Tao Sun, Wushi Cui, Jiaxuan Zou, Weinan Yang, Liang Chen, Jian Xiao, Shicheng Wang, Tao Zhang, Jianqiao Hong, An Liu, Haobo Wu   +12 more
wiley   +1 more source

Resolving the Interference of Anti-CD38 Antibodies on Blood Compatibility Assays Using CD38 "Baitbodies" Approach. [PDF]

J Immunol Res
Gnann DC, Steinke S, Garritsen HSP, Hust M.   +3 more
europepmc   +1 more source

Engineering Osteoimmune Responses with Functionalized Orthopedic Implants for Post‐Operative Osteosarcoma Treatment

Advanced Science, EarlyView.
Osteosarcoma is the most common primary bone tumor with limited treatment options and a terrible prognosis. This review provides a comprehensive summary of the recent development of osteoimmunomodulatory implants for post‐operative osteosarcoma treatment, of which the potential utility in evoking durable anti‐osteosarcoma immunity and accelerating bone
Yilong Dong, Lingshuang Wang, Hui Zhang, Menghuan Li, Zhong Luo, Yan Hu, Chunyuan Cai   +6 more
wiley   +1 more source

Longitudinal study of the immunological response to the SARS-CoV-2 vaccine in Instituto Português de Oncologia of Coimbra professionals. [PDF]

IJID Reg
Freitas FP, Codeço C, Correia DL, Oliveira J, Veiga PM, Cunha N, Rigueiro G, Paiva AR, Carrito B, Soares R.   +9 more
europepmc   +1 more source

Immunogenic Properties and Safety of a Quadrivalent Inactivated Subunit Adjuvanted Influenza Vaccine in Adults Aged 18 to 85 Years at the End of the COVID-19 Pandemic in the 2022-2023 Season. [PDF]

Vaccines (Basel)
Kostinov MP, Kostinova AM, Iushkova S, Gladkova L, Vlasenko A, Dagil Y, Kvasova M, Kameleva A, Kachnova A, Solovеva I, Khamidulina A, Prutskova E, Mekhantseva I, Andreeva N, Polishchuk VB, Mana YA, Kostinov AM.   +16 more
europepmc   +1 more source

From Epistaxis to a Platelet Count of Four: A Rare Presentation of Teicoplanin-Induced Thrombocytopenia. [PDF]

Cureus
Shrestha A, Jain U, Mathew A, Ha K.
europepmc   +1 more source

IgE based therapeutics are an emerging modality in cancer treatment. [PDF]

Discov Oncol
Kumari S, Ghosh S, Doerner A.
europepmc   +1 more source

Advancing immunotherapy via multiple immune cells co-engagement. [PDF]

Front Immunol
Li H, Zhang Y, Wei Q, Sun Q, Lin F, Chen PR.   +5 more
europepmc   +1 more source

Sputnik V update: safety and neutralizing antibodies in healthy adults and adolescents. [PDF]

Front Immunol
Shuliakova IV, Grousova DM, Iliukhina AA, Dzharullaeva AS, Lubenets NL, Ordzhonikidze MK, Izhaeva FM, Erokhova AS, Zorkov ID, Azizyan VV, Boeva ZD, Reshetnikov DA, Ermolova IA, Lega VA, Kovyrshina AV, Bukhtin KM, Romanova LP, Alekseeva EI, Borzakova SN, Rachina SA, Rusanova MG, Ozharovskaia TA, Popova O, Zrelkin DI, Zubkova OV, Tukhvatulin AI, Tukhvatulina NM, Shcheblyakov DV, Favorskaya IA, Esmagambetov IB, Karpov AP, Semikhin AS, Pochtovyi AA, Naroditskiy BS, Gushchin VA, Gintsburg AL, Logunov DY.   +36 more
europepmc   +1 more source